News
Kim Mizar-Stem
Efforts to combat methamphetamine abuse in Oklahoma already have resulted in restrictions on the sale of pseudoephedrine, a chief ingredient in meth. Now, some in the state law enforcement community are hoping to take that battle a step further by making the medicine a Schedule III drug.



